The androgen receptor is a tumour suppressor in estrogen receptor positive breast cancer

被引：0
|
作者：
Lim, Elgene [1 ]
Hickey, Theresa A. [2 ]
Selth, Luke A. [2 ]
Chia, Kee Ming [1 ]
Milioli, Heloisa H. [1 ]
Roden, Daniel [1 ]
Laven-Law, Geraldine [2 ]
Jindal, Shalini [2 ]
Hui, Mun [1 ]
Ebrahimie, Esmaeil [2 ]
Birrell, Stephen N. [2 ]
Stelloo, Suzan [3 ]
Caldon, C. Elizabeth [1 ]
Finlay-Schultz, Jessica [4 ]
Abdel-Fatah, Tarek M. [5 ]
Ellis, Ian O. [5 ]
Zwart, Willbert [3 ]
Palmieri, Carlo [5 ]
Sartorius, Carol A. [4 ]
Swarbrick, Alex [1 ]
Carroll, Jason S. [6 ]
Tilley, Wayne D. [2 ]
机构：
[1] Univ New South Wales, Garvan Inst Med Res, Sydney, NSW, Australia
[2] Univ Adelaide, Dame Roma Mitchell Canc Res Lab, Adelaide, SA, Australia
[3] Netherlands Canc Inst, Oncode Inst, Amsterdam, Netherlands
[4] Univ Colorado, Aurora, CO USA
[5] Univ Liverpool, Liverpool, Merseyside, England
[6] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-GS2-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
GS2-03
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The effect of EPO-receptor in estrogen receptor positive breast cancer
    Vaapil, Marica C.
    Reinbothe, Susann
    Larsson, Anna-Maria
    Wigerup, Caroline
    Sun, Jianmin
    Jogi, Annika
    Neumann, Drorit
    Ronnstrand, Lars
    Pahlman, Sven
    CANCER RESEARCH, 2014, 74 (19)
  • [32] Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
    Chan, Melissa
    Chang, Martin C.
    Gonzalez, Rosa
    Lategan, Belinda
    del Barco, Elvira
    Vera-Badillo, Francisco
    Quesada, Paula
    Goldstein, Robyn
    Cruz, Ignacio
    Ocana, Alberto
    Cruz, Juan J.
    Amir, Eitan
    PLOS ONE, 2015, 10 (07):
  • [33] Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast Cancer
    Wei, Lixuan
    Gao, Huanyao
    Yu, Jia
    Zhang, Huan
    Nguyen, Thanh Thanh L.
    Gu, Yayun
    Passow, Marie R.
    Carter, Jodi M.
    Qin, Bo
    Boughey, Judy C.
    Goetz, Matthew P.
    Weinshilboum, Richard M.
    Ingle, James N.
    Wang, Liewei
    CANCER RESEARCH, 2023, 83 (03) : 456 - 470
  • [34] Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
    Anestis, Aristomenis
    Sarantis, Panagiotis
    Theocharis, Stamatios
    Zoi, Ilianna
    Tryfonopoulos, Dimitrios
    Korogiannos, Athanasios
    Koumarianou, Anna
    Xingi, Evangelia
    Thomaidou, Dimitra
    Kontos, Michalis
    Papavassiliou, Athanasios G.
    Karamouzis, Michalis V.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (05) : 1221 - 1233
  • [35] Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
    Aristomenis Anestis
    Panagiotis Sarantis
    Stamatios Theocharis
    Ilianna Zoi
    Dimitrios Tryfonopoulos
    Athanasios Korogiannos
    Anna Koumarianou
    Evangelia Xingi
    Dimitra Thomaidou
    Michalis Kontos
    Athanasios G. Papavassiliou
    Michalis V. Karamouzis
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 1221 - 1233
  • [36] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [37] The origin of estrogen receptor α-positive and α-negative breast cancer
    Clarke, Robert B.
    Sims, Andrew H.
    Howell, Anthony
    HORMONAL CARCINOGENESIS V, 2008, 617 : 79 - 86
  • [38] The Androgen Receptor Restricts Estrogen Receptor Alpha DNA Binding in Breast Cancer Cells
    Hickey, Theresa E.
    Robinson, Jessica L. L.
    Moore, Nicole L.
    Russell, Roslin
    Selth, Luke
    Rueda, Oscar
    Caldas, Carlos
    Carroll, Jason S.
    Tilley, Wayne D.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [39] Androgen receptor agonism in advanced oestrogen receptor-positive breast cancer
    Chen, Nan
    Nanda, Rita
    LANCET ONCOLOGY, 2024, 25 (03): : 269 - 270
  • [40] Emergence of constitutively active estrogen receptor mutations in advanced estrogen receptor positive breast cancer
    Jeselsohn, R. M.
    Yelensky, R.
    Buchwalter, G.
    Frampton, G.
    Meric-Bernstam, F.
    Cristofanilli, M.
    Arteaga, C. L.
    Balko, J.
    Gilmore, L.
    Schnitt, S.
    Come, S. E.
    Pusztai, L.
    Stephens, P.
    Miller, V. A.
    Brown, M.
    CANCER RESEARCH, 2013, 73
12345